Investigation of the Effects of Longvida Curcumin on Cognitive Function, Mood and Biomarkers of Health.

Phase 3

Active, not recruiting

• Conditions: Cognitive function; Psychological wellbeing (mood, stress fatigue, sleep); Cardiovascular function; Brain function (fMRI); Inflammation; Oxidative Stress; Mental Health - Studies of normal psychology, cognitive function and behaviour; Alternative and Complementary Medicine - Herbal remedies; Neurological - Studies of the normal brain and nervous system

• Registration Number: ACTRN12616000484448
• Lead Sponsor: Swinburne University of Technology, Centre for Human Psychopharmacology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-04-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1.Aged 50-85 years.
2.Willing and able to provide written informed consent.
3.Understand and willing and able to comply with all study procedures.
4.No history of stroke, neurological conditions (e.g. Parkinson’s, epilepsy), depression, psychiatric disorders, low base line intellect, alcohol abuse past / present.
5.Free from dementia.
6.Fluent in written and spoken English.
7.Must have normal or corrected vision and not colour blind.
8.Free from medical conditions which may affect ability to participate in the study
9.Participants taking part in the MRI sub-study must be right handed

Exclusion Criteria

1.Any significant concurrent illness including any auto-immune disorder, bleeding disorders, currently impaired cardiovascular function, Type I diabetes, glaucoma, uncontrolled high blood pressure or gallstones.
2.Any known or suspected food allergies
3.Smokers and users of recreational drugs (except alcohol and other food grade actives).
4.Have participated in any other study involving an investigational product in the last 4 weeks.
5.Taking anti-coagulant drugs or anti-cholinergics or acetylcholinesterase inhibitors.
6.Taking steroid medications.
7.Taking vitamins or herbal supplements that are reasonably expected to influence study measures.
8.Left-handed participants will be ineligible to take part in the MRI sub-study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified